The advantages of SGLT2 inhibitors over DPP-4 inhibitors cannot be ascribed to differences in their antihyperglycemic effects, since in the large-scale trials, the two classes of drugs produced similar decreases in blood glucose during long-term treatment
Market & Policy Implications: A Quiet Race Is Already Starting Pharma companies may move quickly if semaglutide trials confirm benefit
Central Florida Orlando, Kissimmee, Winter Park, Clermont, Tampa, St
Semaglutide significantly reduces appetite, and some patients inadvertently under-eat relative to their activity level, especially as doses increase
Ozempic works primarily as a GLP-1 receptor agonist
Net prices of branded GLP-1s would have to come down further in order for them to be cost-saving within, say, a two-year time period